The U.S. Food and Drug Administration (FDA) has authorized one of the first COVID-19 tests that measures the amount of neutralizing antibodies produced by the body’s immune system after exposure to the virus, a “new generation” of coronavirus test designed to tell how well someone is protected against infection.

Read more at CNBC